A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease
Clinical trial NCT01767311 · COMPLETED
Trial details
- NCT number
- NCT01767311
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-20
- Primary completion
- 2024-12-10
- Enrollment
- 856
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.